Want to join the conversation?
$DEPO said the U.S. District Court of New Jersey judge entered order enjoining any of Actavis Elizabeth, Actavis, Alkem, Ascend Laboratories, Roxane and Watson Laboratories from marketing generic versions of any of NUCYNTA, NUCYNTA ER or NUCYNTA oral solution prior to the Court's issuance of a decision in the pending patent litigation.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?